M6620 (VX-970, Berzosertib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M6620 (VX-970, Berzosertib), covering 2025-06-27 to 2025-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer [Phase 1]